期刊文献+

RBD与突触核蛋白病及tau蛋白病的研究进展 被引量:1

Research progress on RBD and its correlation with synuclein opathy and tauopathy
原文传递
导出
摘要 快速眼动睡眠期行为障碍(RBD)的特征是快速眼动睡眠期出现骨骼肌迟缓现象消失,并出现突出的运动行为。RBD与突触核蛋白病及tau蛋白病密切相关。本文将对RBD的病因、临床表现、诊断、发病机制及其与突触核蛋白病及tau蛋白病的关联做综述,旨在提高对RBD作为突触核蛋白病及tau蛋白病早期生物学标志的认识。 Sleep behavior disorder(RBD) is characterized by loss of muscular atonia and prominent motor behavior during rapid eye movement sleep. RBD is strongly assiociated with synuclein opathy and tauopathy. This paper reviewed the pathology,clinical manifestation,diagnosis,pathogenesis,and its correlation with synuclein opathies and tauopathies of RBD to improve the recognition of RBD as an early marker for synuclein opathies and tauopathies.
出处 《中国城乡企业卫生》 2015年第1期15-17,共3页 Chinese Journal of Urban and Rural Enterprise Hygiene
关键词 快速眼动睡眠行为障碍 突触核蛋白病 tau蛋白病 Rapid eye movement sleep behavioral disorder synuclein opathy tauopathy
  • 相关文献

参考文献15

二级参考文献117

  • 1Sergeant N, Bretteville A, Hamdane M, et al. Biochemistry of tau in Alzheimer's disease and related neurological disorders [ J ]. Expert Rev Proteomics,2008 ; 5 (2) :207 -24.
  • 2Boeve BF, Hutton M. Refining frontotemporal dementia with parkinsonism linked to chromosome 17 :introducing FTDP-17 (MAPT) and FTDP-17 ( PGRN ) [ J ]. Arch Neurol,2008 ;65 (4) :460-4.
  • 3Jellinger KA. Neuropathological aspects of Alzheimer disease, Parkinson disease and frontotemporal dementia [ J ]. Neurodegener Dis, 2008 ; 5 ( 3- 4) :118-21.
  • 4Ballatore C, Lee VM, Trojanowski JQ. tau-mediated neurodegeneration in Alzheimer's disease and related disorders[ J ]. Nat Rev Neurosci ,2007;8 (9) :663-72.
  • 5Perez M, Santa-Maria I ,Tortosa E, et al. The role of the VQIVYK peptide in tau protein phosphorylation [ J ]. J Neurochem, 2007 ; 103 ( 4 ) : 1447- 60.
  • 6Liu Y, Liu F, Iqbal K, et al. Decreased glucose transporters correlate to abnormal hyperphosphorylation of tau in Alzheimer disease [ J ]. FEBS Lett,2008 ;582(2) :359-64.
  • 7Deng Y, Li B, Liu F,et al. Regulation between O-GlcNA cylation and phospborylation of neurofilament-M and their dysregulation in Alzheimer disease[ J]. FASEB J,2008 ;22 ( 1 ) :138-45.
  • 8Terwel D, Lasrado R, Snauwaert J,et al. Changed conformation of mutant tau-P301L underlies the moribund tauopathy, absent in progressive, nonlethal axonopathy of tau-4R/2N transgenic mice[J]. J Biol Chem,2005 ;280(5 ) :3963-73.
  • 9Maeda S, Sahara N, Saito Y, et al. Granular tau oligomers as intermediates of tau filaments [ J ]. Biochemistry,2007 ;46 ( 12 ) :3856-61.
  • 10de la Torte JC. Pathophysiology of neuronal enemy crisis in Alzheimer's disease[J]. Neurodegener Dis,2008 ;5 ( 34 ) : 126-32.

共引文献28

同被引文献4

引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部